Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape

References

• PerouCMMolecular stratification of triple-negative breast cancersOncologist201116Suppl 16170
   PubMed Web of Science ®Google Scholar
• MiyanMSchmidt-MendeJKiesslingRPoschkeIde BonifaceJDifferential tumor infiltration by T-cells characterizes intrinsic molecular subtypes in breast cancerJ Transl Med20161422727473163
   PubMed Web of Science ®Google Scholar
• MaoYQuQChenXHuangOWuJShenKThe prognostic value of tumor-infiltrating lymphocytes in breast cancer: A systematic review and meta-analysisPLoS One2016114e015250027073890
   PubMed Web of Science ®Google Scholar
• VajariaBNPatelPSGlycosylation: A hallmark of cancer?Glycoconj J201734214715627975160
   PubMed Web of Science ®Google Scholar
• SchultzMJSwindallAFBellisSLRegulation of the metastatic cell phenotype by sialylated glycansCancer Metastasis Rev2012313–450151822699311
   PubMed Web of Science ®Google Scholar
• LuJGuJSignificance of β-galactoside α2,6 sialyltranferase 1 in cancersMolecules20152057509752725919275
   PubMed Web of Science ®Google Scholar
• WreschnerDHMcGuckinMAWilliamsSJGeneration of ligand-receptor alliances by “SEA” module-mediated cleavage of membrane-associated mucin proteinsProtein Sci200211369870611847293
   PubMed Web of Science ®Google Scholar
• LillehojEPHyunSWFengCNEU1 sialidase expressed in human airway epithelia regulates epidermal growth factor receptor (EGFR) and MUC1 protein signalingJ Biol Chem2012287118214823122247545
   PubMed Web of Science ®Google Scholar
• GarbarCMascauxCGiustinianiJAutophagy is decreased in triple-negative breast carcinoma involving likely the MUC1-EGFR-NEU1 signalling pathwayInt J Clin Exp Pathol2015854344435526191126
   PubMed Web of Science ®Google Scholar
• ParkJJYiJYJinYBSialylation of epidermal growth factor receptor regulates receptor activity and chemosensitivity to gefitinib in colon cancer cellsBiochem Pharmacol201283784985722266356
   PubMed Web of Science ®Google Scholar
• MaXDongWSuZFunctional roles of sialylation in breast cancer progression through miR-26a/26b targeting ST8SIA4Cell Death Dis2016712e256128032858
   PubMedGoogle Scholar
• GarbarCMascauxCGiustinianiJMerroucheYBensussanAChemotherapy treatment induces an increase of autophagy in the luminal breast cancer cell MCF7, but not in the triple-negative MDA-MB231Sci Rep201771720128775276
   PubMedGoogle Scholar
• MadsenCBLavrsenKSteentoftCVester-ChristensenMBClausenHWandallHHPedersenAEGlycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killingPLoS One201389e7241324039759
   PubMed Web of Science ®Google Scholar
• LoiSSirtaineNPietteFPrognostic and predictive value of tumor-infiltrating lymphocytes in a Phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98J Clin Oncol201331786086723341518
   PubMed Web of Science ®Google Scholar
• LuenSJSalgadoRFoxSTumour-infiltrating lymphocytes in advanced HER2-positive breast cancer treated with pertuzumab or placebo in addition to trastuzumab and docetaxel: A retrospective analysis of the CLEOPATRA studyLancet Oncol2017181526227964843
   PubMed Web of Science ®Google Scholar
• HudakJECanhamSMBertozziCRGlycocalyx engineering reveals a siglec-based mechanism for NK cell immunoevasionNat Chem Biol2014101697524292068
   PubMed Web of Science ®Google Scholar
• PerdicchioMCornelissenLAStreng-OuwehandITumor sialylation impedes T cell mediated anti-tumor responses while promoting tumor associated-regulatory T cellsOncotarget2016788771878226741508
   PubMedGoogle Scholar
• OgataSMaimonisPJItzkowitzSHMucins bearing the cancer-associated sialosyl-Tn antigen mediate inhibition of natural killer cell cytotoxicityCancer Res19925217474147461511439
   PubMed Web of Science ®Google Scholar
• BeatsonRTajadura-OrtegaVAchkovaDThe mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9Nat Immunol201617111273128127595232
   PubMed Web of Science ®Google Scholar
• TanidaSAkitaKIshidaABinding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growthJ Biol Chem201328844318423185224045940
   PubMed Web of Science ®Google Scholar
• MarcosNTPinhoSGrandelaCRole of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigenCancer Res200464197050705715466199
   PubMed Web of Science ®Google Scholar
• SolatyckaAOwczarekTPillerFMUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferaseGlycobiology20122281042105422534569
   PubMed Web of Science ®Google Scholar
• BitlerBGGoverdhanASchroederJAMUC1 regulates nuclear localization and function of the epidermal growth factor receptorJ Cell Sci2010123Pt 101716172320406885
   PubMed Web of Science ®Google Scholar
• DharmarajNeerajaEngelBJCarsonDDActivated EGFR stimulates MUC1 expression in human uterine and pancreatic cancer cell linesJ Cell Biochem2013114102314232223686469
   PubMed Web of Science ®Google Scholar
• SenapatiSDasSBatraSKMucin-interacting proteins: from function to therapeuticsTrends Biochem Sci201043542364519913432
   PubMed Web of Science ®Google Scholar
• ChenXWangLZhaoYST6Gal-I modulates docetaxel sensitivity in human hepatocarcinoma cells via the p38 MAPK/caspase pathwayOncotarget2016732519555196427340870
   PubMedGoogle Scholar
• ChakrabortyADorsettKATrummellHQST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damageJ Biol Chem2018293398499429191829
   PubMed Web of Science ®Google Scholar
• YenHYLiuYCChenNYEffect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibitionProc Natl Acad Sci USA2015112226955696025971727
   PubMed Web of Science ®Google Scholar
• PeirisDSpectorAFLomax-BrowneHCellular glycosylation affects Herceptin binding and sensitivity of breast cancer cells to doxorubicin and growth factorsSci Rep201774300628223691
   PubMed Web of Science ®Google Scholar
• WimanaZGebhartGGuiotTN-acetylcysteine breaks resistance to trastuzumab caused by MUC4 overexpression in human HER2 positive BC-bearing nude mice monitored by 89Zr-Trastuzumab and 18F-FDG PET imagingOncotarget2017834561855619828915583
   PubMedGoogle Scholar
• LaporteBGonzalez-HilarionSMaftahAPetitJMThe second bovine β-galactoside-α2,6-sialyltransferase (ST6Gal II): Genomic organization and stimulation of its in vitro expression by IL-6 in bovine mammary epithelial cellsGlycobiology200919101082109319617256
   PubMed Web of Science ®Google Scholar
• Groux-DegrooteSKrzewinski-RecchiMACazetAIL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated LewisX epitopes in the human bronchial mucosaBiochem J2008410121322317944600
   PubMedGoogle Scholar
• BassagañasSAllendeHCoblerLOrtizMRLlopEde BolósCPeracaulaRInflammatory cytokines regulate the expression of glycosyltransferases involved in the biosynthesis of tumor-associated sialylated glycans in pancreatic cancer cell linesCytokine201575119720625934648
   PubMed Web of Science ®Google Scholar